Volume 12, Issue 4 (11-2022)                   JABS 2022, 12(4): 397-405 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rezaie Keikhaie K, Rezaie Kahkhaie L, Saravani K, Shahraki Z, Ghaffari H R, Badi Baigan S, et al . The Effect of Intravenous and Oral Fluid Therapy on Women with Third Trimester Oligohydramnios of Pregnancy and the Fetus. JABS 2022; 12 (4) :397-405
URL: http://jabs.fums.ac.ir/article-1-2802-en.html
1- Department of Obstetrics and Gynecology, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran
2- Department of Infectious Diseases, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran
3- Department of Internal Medicine, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran
4- Department of Anatomy, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran
5- Student Research Committee, Zabol University of Medical Sciences, zabol, Iran
6- Department of Cellular & Molecular, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
7- Department of of Microbiology, Zabol University of Medical Sciences, Zabol, Iran
Abstract:   (799 Views)
Background & Objective: Adequate amniotic fluid volume is one of the most important aspects of fetal health and Oligohydramnios refers to amniotic fluid volume that is less than expected for gestational age. The aim of this study was to compare the trend of amniotic fluid changes in the two groups of oral and injectable before and after fluid therapy.
Materials & Methods: In the present study, pregnant women with oligohydramnios in the third trimester referring to Amir Al-Momenin Hospital (Zabol, 2019) were randomly divided into two groups of case. The first group received oral water and the second group was treated with serum therapy. Eventually, all patients underwent ultrasonography and their AFI was recalculated and compared. Data was analyzed using SPSS 20 statistical software.
Results: The results of the study showed that there was no statistically significant difference between the amniotic fluid index before fluid therapy in the oral and injectable (serum therapy) groups (p = 0.426). After fluid therapy, the amniotic fluid index in the oral group was significantly higher than the injected group (p <0.001).
Although in both oral and injectable groups, the amniotic fluid index increased significantly after treatment (p <0.001), the increase in the oral group was significantly higher than the injectable group.
Conclusion: The results of this study showed that oral and intravenous fluid therapy improves the amniotic fluid index more than injectable fluid therapy.

 
Full-Text [PDF 443 kb]   (715 Downloads)    
Type of Study: Research | Subject: Medical Genetics
Received: 2022/02/27 | Accepted: 2022/08/9 | Published: 2022/12/28

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advanced Biomedical Sciences

Designed & Developed by: Yektaweb

Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)